|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
25,230,000 |
Market
Cap: |
298.98(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$4.8 - $14.07 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Verastem is a late stage development biopharmaceutical company, with ongoing registration directed trials, focused on developing and commercializing medicines for patients battling cancer. Co.'s product candidates, VS-6766 and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors. VS-6766 is an orally available small molecule rapidly accelerated fibrosarcoma/ mitogen-activated protein kinase kinase clamp. Defactinib is an oral small molecule inhibitor of Focal Adhesion Kinase and proline-rich tyrosine kinase that is being evaluated as a potential combination therapy for various solid tumors.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
1,735 |
21,833 |
25,311 |
165,018 |
Total Sell Value |
$18,442 |
$258,319 |
$292,764 |
$385,800 |
Total People Sold |
4 |
4 |
4 |
4 |
Total Sell Transactions |
9 |
20 |
37 |
63 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gagnon Robert E. |
Director |
|
2022-12-19 |
4 |
S |
$0.37 |
$529 |
D/D |
(1,429) |
574,717 |
|
-16% |
|
Paterson Dan |
President and COO |
|
2022-12-16 |
4 |
S |
$0.40 |
$6,270 |
D/D |
(15,676) |
466,782 |
|
-1% |
|
Stuglik Brian M |
Chief Executive Officer |
|
2022-12-16 |
4 |
S |
$0.40 |
$10,065 |
D/D |
(25,162) |
1,126,076 |
|
-1% |
|
Gagnon Robert E. |
Director |
|
2022-12-16 |
4 |
S |
$0.40 |
$4,963 |
D/D |
(12,408) |
576,146 |
|
-1% |
|
Gagnon Robert E. |
Director |
|
2022-12-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
588,554 |
|
-18% |
|
Calkins Daniel |
Vice President of FinanceOffic |
|
2022-10-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
99,837 |
|
2% |
|
Paterson Dan |
President and COO |
|
2022-09-19 |
4 |
S |
$1.13 |
$3,148 |
D/D |
(2,786) |
482,458 |
|
43% |
|
Gagnon Robert E. |
Chief Financial Officer |
|
2022-09-19 |
4 |
S |
$1.13 |
$1,523 |
D/D |
(1,348) |
588,554 |
|
43% |
|
Stuglik Brian M |
Chief Executive Officer |
|
2022-09-19 |
4 |
S |
$1.13 |
$3,791 |
D/D |
(3,355) |
1,151,238 |
|
43% |
|
Stuglik Brian M |
Chief Executive Officer |
|
2022-08-01 |
4 |
S |
$1.08 |
$6,327 |
D/D |
(5,858) |
1,154,593 |
|
56% |
|
Paterson Dan |
President and COO |
|
2022-06-21 |
4 |
S |
$1.14 |
$3,079 |
D/D |
(2,701) |
485,244 |
|
62% |
|
Stuglik Brian M |
Chief Executive Officer |
|
2022-06-21 |
4 |
S |
$1.14 |
$3,833 |
D/D |
(3,362) |
1,160,451 |
|
62% |
|
Gagnon Robert E. |
Chief Financial Officer |
|
2022-06-21 |
4 |
S |
$1.14 |
$1,540 |
D/D |
(1,351) |
589,902 |
|
62% |
|
Gagnon Robert E. |
Chief Financial Officer |
|
2022-05-16 |
4 |
S |
$1.03 |
$17,126 |
D/D |
(16,627) |
591,253 |
|
10% |
|
Paterson Dan |
President and COO |
|
2022-05-16 |
4 |
S |
$1.03 |
$5,138 |
D/D |
(4,988) |
487,945 |
|
10% |
|
Stuglik Brian M |
Chief Executive Officer |
|
2022-05-16 |
4 |
S |
$1.03 |
$14,208 |
D/D |
(13,794) |
1,163,813 |
|
10% |
|
Gagnon Robert E. |
Chief Financial Officer |
|
2022-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
607,880 |
|
- |
|
Paterson Dan |
President and COO |
|
2022-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
492,933 |
|
- |
|
Stuglik Brian M |
Chief Executive Officer |
|
2022-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
1,177,607 |
|
- |
|
Stuglik Brian M |
Chief Executive Officer |
|
2022-05-02 |
4 |
S |
$1.41 |
$8,258 |
D/D |
(5,857) |
1,127,607 |
|
11% |
|
Paterson Dan |
President and COO |
|
2022-03-21 |
4 |
S |
$1.27 |
$3,579 |
D/D |
(2,818) |
477,933 |
|
16% |
|
Gagnon Robert E. |
Chief Financial Officer |
|
2022-03-21 |
4 |
S |
$1.27 |
$1,789 |
D/D |
(1,409) |
557,880 |
|
16% |
|
Stuglik Brian M |
Chief Executive Officer |
|
2022-03-21 |
4 |
S |
$1.27 |
$4,454 |
D/D |
(3,507) |
1,133,464 |
|
16% |
|
Stuglik Brian M |
Chief Executive Officer |
|
2022-01-31 |
4 |
S |
$1.48 |
$8,429 |
D/D |
(5,695) |
1,136,971 |
|
17% |
|
Lampert Mark N |
10% Owner |
|
2022-01-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,630,934 |
|
-20% |
|
168 Records found
|
|
Page 3 of 7 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|